Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 16-21

  Sanno, Naoko ^a   Teramoto, Akira ^b   Sugiyama, Makoto ^b   Itoh, Yoshiko ^a   Osamura, R Yoshiyuki ^a  

^a TOKAI UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Catalyzed signal amplification (CSA); Gonadotropin; Immunohistochemistry; Nonfunctioning adenoma; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; GLYCOPROTEIN; GONADOTROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GONADOTROPIN RELEASE; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0029893802     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.16     Document Type: Article

References (26)

1. Kovacs K. Light and electron microscopic pathology of pituitary tumors: Immunohistochemistry. In: Black PML, Zarvas NT, Ricgway EC, et al, eds. Secretory Tumors of the Pituitary Gland. New York: Raven Press, 1984, pp 365-376.
2. DeStephono DB, Lloyd RV, Pike AM, et al. Pituitary adenomas: An immunohistochemical study of hormone production and chromogranin localization. Am J Pathol 1984;116:464-472.
3. Esiri MM, Adams CBT, Burke C, et al. Pituitary adenomas: Immunohistology and ultrastructural analysis of 118 tumors. Acta Neuropathol 1983;62:1-4.
4. Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985;6:552-63.
5. Snyder PJ, Bashey HM, Phillips JL, Gennarellli TA. Comparison of hormonal secrtory behavior of gonadotroph cell adenomas in vivo and in culture. J Clin Endocrinol Metab 1985;61:1061-065.
6. Surmont DWA, Winslow CLJ, Loizou M, White MC, Adams EF, Mashiter K. Goandotrophin and alpha subunit secretion by human "functionless" pituitary adenomas in cell culture: Long-term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone. Clin Endocrinol (Oxf) 1983;19: 325-36.
7. Asa SL, Gerne BM, Singer W, Horvalh E, Kovacs K, Smyth HS. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986;62: 1011-019.
8. Black PM, Hsu DW, Klibanski A, et al. Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 1987;66:244-50.
9. Mukai K. Pituitary adenomas: Immunohistochemical study of 150 tumors with clinicopathologic correlation. Cancer 1983;52: 648-653.
10. Sanno N, Teramoto A, Inada K, Osamura Y. Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas. Brain and Nerve 1992;44:745-753.
11. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification: Application to immunoassays. J Immunol Methods 1989;125: 279-285.
12. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992;40:1457-1463.
13. Kestens HMJ, Poddighe PJ, Hanselaar AJM. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995;43:347-352.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
15. Kwekkeboom DJ, de-Jong FH, Lamberts SW. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: Relation of sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab 1989;68:1128-1135.
16. Jameson JL, Lindell CM, Habener JF. Gonadotropin and thyrotropin alpha- and beta-subunit gene expression in normal and neoplastic tissues characterized using specific messenger ribonucleic acid hybridization probes. J Clin Endocrinol Metab 1987;64:319-327.
17. Matsuno A, Teramoto A, Takekoshi S, Sanno N, Osamura RY, Kirino T. HGH, PRL, and ACTH gene expression in clinically nonfunctioning adenomas detected with non-radioisotopic in situ hybridization method. Endocrine Pathology 1995;6:13-20.
18. Kovacs K, Horvath E, Ryan N, Ezrin C. Null cell adenoma of the human pituitary. Virchows Archiv 1980;387:165-174.
19. Kovacs K, Asa SL, Horvath E, et al. Null cell adenomas of the pituitary: Attempts to resolve their cytogenesis. In: Lechago J, Kameya T, eds. Endocrine Pathology Update. vol 1. Philadelphia: Field and Wood, 1990, pp 17-31.
20. Saeger W, Gunzl H, Meyer M, Schulze C, Ludecke DK. Immunohistological studies on clinically silent pituitary adenomas. Endocrine Pathology 1990;1:37-44.
21. Snyder PJ. Gonadotroph adenomas of the pituitary. Endocr Rev 1985;6:552-563.
22. Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Null cell adenomas, oncocytomas, and goandotroph adenomas of the human pituitary: An immunocytochemical and ultrastructural analysis of 300 cases. Endocrine Pathology 1993;4:20-27.
23. Banerjee D, Pettit S. Endogenous avidin-binding activity in human lymphoid tissue. J Clin Pathol 1984;37:223-225.
24. Escribano LM, Gabriel LC, Villa E, et al. Endogenous peroxidase activity in human cutaneous and adenoidal mast cells. J Histochem Cytochem 1987;35:213-220.
25. Young WF Jr, Scheithauer BW, Kovacs K, Horvath E, Davis DH. Gonadotroph cell adenomas of the pituitary: Clinical, immunocytochemical, and ultrastructural analysis of 78 cases. Endocrine Pathology 1992;3(suppl1):S63.
26. Osamura RY, Sanno N, Teramoto A. Clinicocyto-functional classification of pituitary adenomas: Proposal of a new classification. Endocrine Pathology 1995;6:253-256.